Neuronetics Inc STIM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $1.20
- Day Range
- $1.19–1.28
- 52-Week Range
- $0.80–4.85
- Bid/Ask
- $1.24 / $1.25
- Shares Outstanding
- 69.59M
- Market Cap
- $84.20M
- Volume/Avg
- 2M / 2M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.60
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 658
- Website
- https://www.neurostar.com
Valuation
|
Metric
|
STIM
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 6.98 |
Price/Sales | 0.60 |
Price/Cash Flow | — |
Price/Earnings
STIM
Financial Strength
|
Metric
|
STIM
|
|---|---|
Quick Ratio | 1.05 |
Current Ratio | 1.67 |
Interest Coverage | −3.72 |
Quick Ratio
STIM
Profitability
|
Metric
|
STIM
|
|---|---|
Return on Assets (Normalized) | −21.01% |
Return on Equity (Normalized) | −115.26% |
Return on Invested Capital (Normalized) | −18.30% |
Return on Assets
STIM
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Jjwzklcc | Sbhxlbr | $154B | |||
| Stryker Corp
SYK
| Lsvnvyygwc | Qsjj | $120B | |||
| Medtronic PLC
MDT
| Cdlzkbmjx | Yyzfb | $103B | |||
| Boston Scientific Corp
BSX
| Lkyhxfmg | Cprrsx | $70B | |||
| Edwards Lifesciences Corp
EW
| Cdgmpfyjy | Jpzntc | $49B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| Wmlpxgpn | Trv | $30B | |||
| DexCom Inc
DXCM
| Tgjzsqndlp | Cqtbggv | $29B | |||
| Koninklijke Philips NV ADR
PHG
| Nfwp | Ffdk | $26B | |||
| Steris PLC
STE
| Cdmdmhklf | Nbzyh | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| Vphksbpswx | Nkpb | $17B |
United States